In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...
For patients with diabetes undergoing Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), overall expenditures ...
Treatment with the highest dose of investigational injectable amycretin -- a unimolecular GLP-1 and amylin receptor agonist -- yielded a 22% weight loss after 36 weeks in a phase Ib/IIa trial, said ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...
Research suggests caffeine can help with weight loss, but a large dose is necessary to create a response. A 2020 review in ...
Kelly Clarkson's weight loss journey is a powerful story of self-care and transformation. From struggling with her weight to ...
A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...
Hosted on MSN7d
Weight-Loss Drugs Can Lower the Risk for 42 Health Conditions—And Raise the Risk for 19 OthersG LP-1 weight-loss drugs are as popular as ever. A Sept. 2024 poll found that roughly 12 percent of U.S. adults have used GLP ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback